2021 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãß°èÇмú´ëȸ-2ÀÏÂ÷ : 2021-11-12±³À°ÀÏÀÚ : 2021-11-12
±³À°Àå¼Ò : ¿Â¿ÀÇÁ¶óÀÎ(¿ÀÇÁ¶óÀÎ : ¼Ò³ëº§Á¦ÁÖ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) 2021 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãß°èÇмú´ëȸ-2ÀÏÂ÷ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ
´ã´çÀÚ : ¹Ú¼Ò¹Î
¿¬¶ôó : 02-398-5055
À̸ÞÀÏ :
office@kscpt.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ¸¶ÃëÅëÁõÀÇÇаú, º´¸®°ú, ÀÀ±ÞÀÇÇаú¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
Á¦ÁÖƯº°ÀÚÄ¡µµ±³À°½Ã°£ : 6 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í ÇöÀåÂü¼® - Á¤È¸¿ø 15¸¸¿ø, ÁØȸ¿ø 7¸¸¿ø, ºñȸ¿ø ÀÏ¹Ý 20¸¸¿ø, ºñȸ¿ø Çлý 10¸¸¿ø¿Â¶óÀÎ Âü¼® - Á¤È¸¿ø 12¸¸¿ø, ÁØȸ¿ø 5¸¸¿ø, ºñȸ¿ø ÀÏ¹Ý 17¸¸¿ø, ºñȸ¿ø Çлý 8¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 09:00~11:30 Young scientist (Æ÷½ºÅÍ ¹ßÇ¥) + 1¸í( IUPHARÆ÷½ºÅÍ °æÁø´ëȸ ¼ö»óÀÚ¹ßÇ¥) ¹ÌÁ¤(¹ÌÁ¤)
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 11:30~12:30 Back to BASIC: »ç¶÷À» »ì¸®´Â ½Å¾à°³¹ß ¹èÁø°Ç ¹Ú»ç´Ô(À̳ëÅ¥¾î)
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 14:15~14:35 Model-informed drug development: an example of esaxerenone, a novel mineralocorticoid receptor blocker for hypertension Dr. Masato Fukae((Daiichi Sankyo))
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 14:35~15:00 Quantitative Predictive Models for the Degree of Disability over Time in Acute Ischemic Stroke Patients Prof. Hyeong-Seok Lim((University of Ulsan))
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 15:00~15:20 Current Status and Challenges of Model-Informed Drug Development and Model-Informed Precision Dosing in Japan Dr. Sou Miyoshi((Pfizer R&D))
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 15:20~15:40 Model Informed Precision Dosing Approach in cPMTb (Center for Personalized Precision Medicine of Tuberculosis) Prof. Yong-Soon Cho((Inje University))
Åä·Ð 11-12 ¿Â¶óÀÎ 15:40~15:55 Q&A ()
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 16:10~16:30 Prediction of transporter-mediated drug-drug interactions using the endogenous biomarkers Dr. Hiroyuki Kusuhara((Graduate School of Pharmaceutical Sciences University of Tokyo))
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 16:30~16:50 Development of metabolic biomarkers to control transplant rejection and long-term survival after kidney transplantation Dr. Mi-Ri Gwon((Kyungpook National University))
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 16:50~17:10 Screening of predictive biomarkers for drug efficacy and safety using lipidomics Dr. Kosuke Saito((National Institute of Health Sciences))
±³À°½Ã°£ 11-12 ¿Â¶óÀÎ 17:10~17:30 Prediction of CYP3A mediated drug-drug interaction using endogenous metabolic markers Dr. Soyoung Lee((Seoul National University)
Åä·Ð 11-12 ¿Â¶óÀÎ 17:30~17:45 Q&A ()